BISC Global launches its Online Pipeline Platform (OP²)
BISC Global, a global bioinformatics consulting company, is officially launching its OP² platform.
“More and more data is being generated and faster than ever before, which has led to the data analysis becoming a significant bottleneck in molecular biology research. With the launch of our OP², we want to help researchers remove this hurdle” said Jan Ghyssaert, COO at BISC Global.
BISC’s OP² is an online platform, enabling researchers to easily upload their data and run a wide range of bioinformatics analysis pipelines, without the need for any bioinformatics skills or infrastructure. The initial platform is launched with 4 different analysis pipelines. One for bulk RNA-seq, one for single-cell RNA-seq, one for somatic variant calling and one for germline variant calling. More pipelines will be added to the platform in the coming weeks and months.
Maarten Braspenning, CEO at BISC Global: “We are very pleased to announce the launch of our OP² platform. With this platform we enable researchers, both in industry and academia, to analyse their sequencing data at the touch of a button, without the need for any bioinformatics skills, servers or cloud infrastructure. By opening the platform to all researchers, using a simple pay-per-sample model, we believe our OP² platform will make it a lot easier and faster for researchers to analyse their data.”
About BISC Global
Founded in 2017 BISC Global has grown to be a Top 10 Bioinformatics Consulting and Services Firm supporting world’s leading pharmaceutical and biotech companies. Through our offices in Ghent, Belgium; Basel, Switzerland; Boston, MA; and San Francisco, CA; BISC Global provides data-analytics, custom tool/pipeline development, and cloud solutions delivered on-site or remotely. By leveraging our global workforce of expert consultants, we support analysis across multiple domains, including machine learning (data mining, pattern recognition, image analysis, (un)supervised learning, neural networks, deep learning, etc.), bioinformatics (single-cell transcriptomics, metabolomics, metagenomics, epigenomics, etc.), and statistics (experimental design, mathematic modelling, signal-to-noise enhancement, and independent data cross-validation). To learn more, please visit www.biscglobal.com.
For more information about OP2, visit op2.biscglobal.com.